Tim Baradet, PhD, HTL/QIHC (ASCP)

Tim Baradet is a seasoned professional specializing in Biomarker Development & Validation for discovery, clinical trials, and patient stratification utilizing Digital Pathology, AI computer analysis, Molecular Pathology, Multiplexed Immunohistochemistry, Multi-spectral Microscopy, Cell Morphology, and Toxicology.

With extensive experience in Digital Pathology & Informatics, Tim excels in developing algorithms for chromogenic and multiplexed fluorescent immunohistochemical quantification, analyzing biomarkers for clinical evaluation, and patient stratification using inForm®, Visiopharm®, and HALO. He is proficient in AI & big data analysis with R programming language.

Tim's expertise extends to imaging techniques such as multi-spectral image acquisition & analysis with Vectra®, Nuance®, and TRIO®, encompassing Bright-Field, Fluorescent, Confocal, and 2-Photon Microscopy, as well as Electron Microscopy (TEM, SEM, EDAX) and Laser Capture Micro-dissection (LCM).

In the realm of Biochemistry, Tim is skilled in techniques including Electrophoresis, ELISA, Western Blotting, Column Purification, FPLC, HPLC, and Light Scattering. He is well-versed in Computing, specializing in Morphometric Analysis, Stereology, and 3-D Modeling.

Tim's Molecular Biology proficiency includes PCR, RT-PCR, FISH, Blotting, and RNAscope®. With a rich and varied professional background, Tim has held key roles at reputable organizations such as Zifo RnD Solutions, Drexel University College of Medicine, Bristol-Myers Squibb, Coleman Research, PathXL, University of Pennsylvania School of Medicine, and Endo Pharmaceuticals.

Tim Baradet's contributions span from his role as a Bioinformatics Systems Analyst & Digital Pathology Consultant to serving as Adjunct Professor of Medicine & Instructor, Senior Research Investigator, Principal Consultant, Digital Pathology Application Scientist, Cancer Biomarker & Digital Pathology Scientist, Scientific Consultant & Adviser, and Research Scientist across different departments and institutions.